Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extractLi Han, Hua Bian, Xueyun Cao et al.|BMC Complementary Medicine and Therapies|2020Cited by 24
A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinomaHaochen Yu, Shengchun Liu, Zhenrong Tang et al.|Aging|2022Cited by 15
Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell‐Induced Ferroptosis in Ovarian CancerJiakai Hou, Weiyi Peng, Ningbo Zheng et al.|Advanced Science|2025Cited by 3
Anlotinib (AL3818) plus pemetrexed in patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A single-arm, open-label, phase II study.Yanna Zhang, He Huang, Jueming Chen et al.|Journal of Clinical Oncology|2020Cited by 1